Gary Goldenberg M.D.
Net Worth
Last updated:
What is Gary Goldenberg M.D. net worth?
The estimated net worth of Dr. Gary Goldenberg M.D. is at least $2,622,077 as of 27 Aug 2024. He owns shares worth $576,877 as insider, has earned $330,490 from insider trading and has received compensation worth at least $1,714,710 in Verrica Pharmaceuticals Inc..
What is the salary of Gary Goldenberg M.D.?
Dr. Gary Goldenberg M.D. salary is $571,570 per year as Chief Medical Officer in Verrica Pharmaceuticals Inc..
How old is Gary Goldenberg M.D.?
Dr. Gary Goldenberg M.D. is 48 years old, born in 1977.
What stocks does Gary Goldenberg M.D. currently own?
As insider, Dr. Gary Goldenberg M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | Chief Medical Officer | 94,261 | $6.12 | $576,877 |
What does Verrica Pharmaceuticals Inc. do?
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Gary Goldenberg M.D. insider trading
Verrica Pharmaceuticals Inc.
Dr. Gary Goldenberg M.D. has made 7 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 3,601 units of VRCA stock worth $8,858 on 27 Aug 2024.
The largest trade he's ever made was exercising 28,699 units of VRCA stock on 24 Jul 2023. As of 27 Aug 2024 he still owns at least 94,261 units of VRCA stock.
Verrica Pharmaceuticals key executives
Verrica Pharmaceuticals Inc. executives and other stock owners filed with the SEC:
- Dr. Gary Goldenberg M.D. (48) Chief Medical Officer
- Mr. Ted White (60) Pres, Chief Executive Officer & Director